A Multicenter Prospective Clinical Cohort Study on the Pathogen Spectrum of HIV/AIDS Complicated With Infection

Launched by ZHEJIANG UNIVERSITY · Feb 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how infections affect people living with HIV/AIDS in China. Researchers want to learn about the types of infections these patients face and how these infections interact with their immune systems. The goal is to find ways to predict and prevent these infections, ultimately helping to reduce the risk of serious health complications and improve treatment options. They will be looking at patterns in infections over time and exploring new methods to help manage these patients' health better.

To participate in this study, individuals must be between 18 and 70 years old, be HIV positive, and agree to take part by signing an informed consent form. Unfortunately, if a doctor feels someone is not suitable for the study for any reason, they may not be able to join. Participants can expect to provide information about their health and possibly undergo tests to help researchers understand more about infections related to HIV. This study is not yet recruiting participants, but it aims to find important insights that could benefit many people living with HIV/AIDS.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Sign the informed consent form.
• • 2. HIV positive.
• • 3. Any gender, age 18 to 70 years old
• Exclusion Criteria:
• • 1.Patients deemed unsuitable by the investigator to participate in the study.